A Randomized Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Major Depression
Top Cited Papers
- 1 August 2006
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of General Psychiatry
- Vol. 63 (8), 856-864
- https://doi.org/10.1001/archpsyc.63.8.856
Abstract
Research from JAMA Psychiatry — A Randomized Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Major DepressionKeywords
This publication has 36 references indexed in Scilit:
- Antidepressants and the Risk of Suicidal BehaviorsJAMA, 2004
- Enhancing neuronal plasticity and cellular resilience to develop novel, improved therapeutics for Difficult-to-Treat depressionBiological Psychiatry, 2003
- Finding the Intracellular Signaling Pathways Affected by Mood Disorder TreatmentsNeuron, 2003
- Modulation of glutamate receptors: Strategies for the development of novel antidepressantsAmino Acids, 2002
- Current perspectives on the development of non-biogenic amine-based antidepressantsPharmacological Research, 2001
- Antidepressants for the new millenniumEuropean Journal of Pharmacology, 1999
- Initiation and adaptation: a paradigm for understanding psychotropic drug actionAmerican Journal of Psychiatry, 1996
- Adaptation of N-Methyl-D-Aspartate (NMDA) Receptors following Antidepressant Treatment: Implications for the Pharmacotherapy of DepressionPharmacopsychiatry, 1996
- Antidepressant-like actions of the polyamine site NMDA antagonist, eliprodil (SL-82.0715)Pharmacology Biochemistry and Behavior, 1995
- Action of various antidepressant treatments reduces reactivity of noradrenergic cyclic AMP-generating system in limbic forebrainNature, 1975